Article

ASTRO's New Guidelines on Post-operative Radiation Therapy for Endometrial Cancer

The American Society for Radiation Oncology (ASTRO) has issued a new guideline, The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline, that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline's executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an open-access article online.

The American Society for Radiation Oncology (ASTRO) has

issued a new guideline, “The Role of Postoperative Radiation Therapy for Endometrial Cancer: An

ASTRO Evidence-Based Guideline,” that details the use of adjuvant radiation therapy in the

treatment of endometrial cancer. The guideline’s executive summary is published in the May-June

2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO.

The

full-length guideline is available as an open-access article online at www.practicalradonc.org.

ASTRO’s Guidelines Panel of 17 leading gynecologic specialists compiled and reviewed

extensive data from 330 studies from MEDLINE, EMBASE and the Specialized Register of the

Cochrane Gynaecological Cancer Review Group published from 1980 to 2011. The data population

selected for the guideline was defined as women of all races, age 18 or older, with stage I-IV

endometrial cancer of any histologic type or grade. The studies included patients who underwent a

hysterectomy followed by no adjuvant therapy, or pelvic and/or vaginal brachytherapy with or

without systemic chemotherapy. The panel identified five key questions about the role of adjuvant

radiation therapy and developed a series of recommendations to address each question.

http://bit.ly/QEFuo9

Source: ASTRO

Read the press release here:

Related Videos
Wanmei Ou, PhD, vice president of product, data analytics, and AI at Ontada
Glenn Balasky, executive director of the Rocky Mountain Cancer Center.
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
Glenn Balasky during a video interview
dr joseph alvarnas
dr joseph alvarnas
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo